Nomura's Wang Thinks Asia Chips Rally Mostly Justified
Original Report
Nomura International Wealth Management North Asia CIO Julia Wang says the chips rally in Asia is mostly justified by earnings growth, but she thinks valuation has also reset. Wang speaks with...
Nomura International Wealth Management North Asia CIO Julia Wang says the chips rally in Asia is mostly justified by earnings growth, but she thinks valuation has also reset. Wang speaks with Haslinda Amin from the sidelines of 'Nomura Investment Forum Asia' in Singapore. (Source: Bloomberg)
Glass House Analysis
Corporate decisions reverberate through local communities—a merger might mean headquarters relocating, a restructuring could eliminate jobs, and strategic shifts affect suppliers and service providers in countless towns. Behind quarterly earnings numbers are real employment decisions, investment choices, and community impacts that shape the economic landscape of regions across the country.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking in 2026 is off to a strong start.
Asia Steps Up Currency Defense as Korea, Indonesia Vow Action
Asian authorities are ramping up their currency defense as high energy costs and bets that the Federal Reserve will raise interest rates pressure them.
SoftBank shares plunge 10% amid broader tech sell-off
Shares of SoftBank fell 10% following an overnight sell-off in the U.S. market on the back of wider profit taking in the tech sector.
Cancer Therapeutics Startup Earli on China Biotech Lead
Cyriac Roeding, CEO and co-founder of cancer therapeutics startup Earli, gives his assessment of China's biotech developments, after predicting a decade ago that the country would become a main...